TY - JOUR
T1 - Fabrication and characterization of chitosan–tamarind seed polysaccharide composite film for transdermal delivery of protein/peptide
AU - Malviya, Rishabha
AU - Tyagi, Anchal
AU - Fuloria, Shivkanya
AU - Subramaniyan, Vetriselvan
AU - Sathasivam, Kathiresan
AU - Sundram, Sonali
AU - Karupiah, Sundram
AU - Chakravarthi, Srikumar
AU - Meenakshi, Dhanalekshmi Unnikrishnan
AU - Gupta, Nandan
AU - Sekar, Mahendran
AU - Sudhakar, Kalvatala
AU - Fuloria, Neeraj Kumar
N1 - Funding Information:
We gratefully appreciate the Galgotias University, India; AIMST university, Malaysia; MAHSA university, Malaysia; University of Science and Technology, Muscat; and Universiti Kuala Lumpur Royal College of Medicine, Malaysia for their support to complete this study.
Publisher Copyright:
© 2021 by the authors. Licensee MDPI, Basel, Switzerland.
PY - 2021/5/1
Y1 - 2021/5/1
N2 - Transdermal drug delivery is used to deliver a drug by eliminating the first-pass metab-olism, which increases the bioavailability of the drug. The present study aims to formulate the chi-tosan–tamarind seed polysaccharide composite films and evaluate for the delivery of protein/pep-tide molecules. Nine formulations were prepared and evaluated by using different parameters, such as physical appearance, folding endurance, thickness of film, surface pH, weight variation, drug content, surface morphology, percentage moisture intake and uptake, drug release kinetics, and drug permeability. The film weight variance was observed between 0.34 ± 0.002 to 0.47 ± 0.003 g. The drug level of the prepared films was found to be between 96 ± 1.21 and 98 ± 1.33μg. Their intake of moisture ranged between 2.83 ± 0.002 and 3.76 ± 0.001 (%). The moisture absorption of the films ranged from 5.33 ± 0.22 to 10.02 ± 0.61 (%). SEM images revealed a smooth film surface, while minor cracks were found in the film after permeation tests. During the first 4 days, drug release was between 13.75 ± 1.64% and 22.54 ± 1.34% and from day 5 to day 6, it was between 72.67 ± 2.13% and 78.33 ± 3.13%. Drug permeation during the first 4 days was 15.78 ± 1.23 %. Drug permeation (%) during the first 4 days was between 15.78 ± 1.23 and 22.49 ± 1.29 and from day 5 to day 6, it was between 71.49 ± 3.21 and 77.93 ± 3.20.
AB - Transdermal drug delivery is used to deliver a drug by eliminating the first-pass metab-olism, which increases the bioavailability of the drug. The present study aims to formulate the chi-tosan–tamarind seed polysaccharide composite films and evaluate for the delivery of protein/pep-tide molecules. Nine formulations were prepared and evaluated by using different parameters, such as physical appearance, folding endurance, thickness of film, surface pH, weight variation, drug content, surface morphology, percentage moisture intake and uptake, drug release kinetics, and drug permeability. The film weight variance was observed between 0.34 ± 0.002 to 0.47 ± 0.003 g. The drug level of the prepared films was found to be between 96 ± 1.21 and 98 ± 1.33μg. Their intake of moisture ranged between 2.83 ± 0.002 and 3.76 ± 0.001 (%). The moisture absorption of the films ranged from 5.33 ± 0.22 to 10.02 ± 0.61 (%). SEM images revealed a smooth film surface, while minor cracks were found in the film after permeation tests. During the first 4 days, drug release was between 13.75 ± 1.64% and 22.54 ± 1.34% and from day 5 to day 6, it was between 72.67 ± 2.13% and 78.33 ± 3.13%. Drug permeation during the first 4 days was 15.78 ± 1.23 %. Drug permeation (%) during the first 4 days was between 15.78 ± 1.23 and 22.49 ± 1.29 and from day 5 to day 6, it was between 71.49 ± 3.21 and 77.93 ± 3.20.
KW - Drug delivery
KW - Hixson-Crowell kinetics
KW - Peptide delivery
KW - Transdermal film
UR - https://www.scopus.com/pages/publications/85106560613
U2 - 10.3390/polym13091531
DO - 10.3390/polym13091531
M3 - Article
AN - SCOPUS:85106560613
SN - 2073-4360
VL - 13
JO - Polymers
JF - Polymers
IS - 9
M1 - 1531
ER -